Gateway for Cancer Research
Eligibility
- Investigator who is ready to conduct a novel, clinical trial in cancer research.
- If applying for the Joint NCI/SPORE/P20 Program, must have SPORE or P20 award.
Description
Gateway funds Phase I and Phase II patient-centered cancer clinical trails that have the potential to shift the paradigm for standard of care.
Keywords:
cancer, clinical trials, biomarkers, gene therapy, basket trials, immunotherapy, therapies, genetics, oncology
Application due:
11/07/25
Award amount:
$200,000 - $1,500,000